Canaccord downgraded Verve Therapeutics (VERV) to Hold from Buy with a price target of $13, down from $39, after Eli Lilly (LLY) announced a definitive agreement to acquire Verve. Lilly will commence ...

Nucor shares are rising Wednesday after the steelmaker outlined better second-quarter profit projections than analysts had ...

Global shares are mostly higher and oil prices have slipped as investors await a decision on interest rates by the Federal ...

Wall Street remained steady as investors awaited the Federal Reserve's policy decision, while global markets reacted to ...

Asian shares were mixed and oil prices advanced Wednesday after the escalation of conflict in the Middle East hit Wall Street. US benchmark crude oil was up 24 cents at $73.51 per barrel. Brent crude, ...